Get started
Author

Thierry Huss

Induction of Protective Immunity in Rodents by Vaccination with a Prokaryotically Expressed Recombinant Fusion Protein Containing a Respiratory Syncytial Virus G Protein Fragment
1997 · Ultan F. Power, Hélène Plotnicky-Gilquin, et al. · Virology · 131
PDF
Identification of Multiple Protective Epitopes (Protectopes) in the Central Conserved Domain of a Prototype Human Respiratory Syncytial Virus G Protein
1999 · Hélène Plotnicky-Gilquin, Liliane Goetsch, et al. · Journal of Virology · 64
Protective Immunity against Respiratory Syncytial Virus in Early Life after Murine Maternal or Neonatal Vaccination with the Recombinant G Fusion Protein BBG2Na
1997 · Christian Brandt, Ultan F. Power, et al. · The Journal of Infectious Diseases · 62
Absence of Lung Immunopathology Following Respiratory Syncytial Virus (RSV) Challenge in Mice Immunized with a Recombinant RSV G Protein Fragment
1999 · Hélène Plotnicky-Gilquin, Thierry Huss, et al. · Virology · 60
PDF
Differential Histopathology and Chemokine Gene Expression in Lung Tissues following Respiratory Syncytial Virus (RSV) Challenge of Formalin-Inactivated RSV- or BBG2Na-Immunized Mice
2001 · Ultan F. Power, Thierry Huss, et al. · Journal of Virology · 52
Functional Efficacy of Dystrophin Expression from Plasmids Delivered to mdx Mice by Hydrodynamic Limb Vein Injection
2009 · Guofeng Zhang, Christine I. Wooddell, et al. · Human Gene Therapy · 45
Use of evans blue dye to compare limb muscles in exercised young and old mdx mice
2009 · Christine I. Wooddell, Guofeng Zhang, et al. · Muscle & Nerve · 43
Muscle Damage After Delivery of Naked Plasmid DNA into Skeletal Muscles Is Batch Dependent
2010 · Christine I. Wooddell, Vladimir M. Subbotin, et al. · Human Gene Therapy · 39
Evaluation of Hydrodynamic Limb Vein Injections in Nonhuman Primates
2010 · Julia O. Hegge, Christine I. Wooddell, et al. · Human Gene Therapy · 38
Dose Response in Rodents and Nonhuman Primates After Hydrodynamic Limb Vein Delivery of Naked Plasmid DNA
2011 · Christine I. Wooddell, Julia O. Hegge, et al. · Human Gene Therapy · 34
The EB66® cell line as a valuable cell substrate for MVA-based vaccines production
2016 · Arnaud Léon, Anne-Laure David, et al. · Vaccine · 27
PDF
Safety and immunogenicity of TG4050: A personalized cancer vaccine in head and neck carcinoma.
2023 · Christian H.H. Ottensmeier, Jean-Pierre Delord, et al. · Journal of Clinical Oncology · 11
Abstract LB205: Feasibility and immunogenicity of adjuvant TG4050, a patient tailored cancer vaccine in head and neck and ovarian cancer
2023 · Ana Lalanne, Camille Jamet, et al. · Cancer Research · 1
Presence of virion protein x (Vpx) of simian immunodeficiency virus SIVmac 251 in target cells in vivo
1995 · Yury Persidsky, Vladimir Liska, et al. · Journal of Medical Primatology · 1
749. Effective Plasmid DNA Dose Range and Promoters for Gene Expression in Muscle Following Hydrodynamic Limb Vein Delivery of pDNA into Rodents and Primates
2006 · Christine I. Wooddell, Julia O. Hegge, et al. · Molecular Therapy
PDF
Proprietes biologiques de proteines regulatrices des virus de l'immunodeficience simienne et humaine : nef et vpx
1995 · Thierry Huss
Works count: 16
Citation count: 608
H-index: 11
I10-index: 12
Year
Topic
Type